Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
09/27/1995 | EP0673648A1 Compositions comprising amphotoic salts of alpha-hydroxy acids and glycerol monocaprylate |
09/27/1995 | EP0673647A1 Dermatological composition containing lactic acid salt |
09/27/1995 | EP0673646A2 Use of Deoxypergualin in the manufacture of a medicament for the treatment of inflammatory-hyperresponsiveness diseases |
09/27/1995 | EP0673545A1 Process and apparatus for etching semiconductor wafers |
09/27/1995 | EP0673431A1 Gene therapy for cystic fibrosis |
09/27/1995 | EP0673425A1 Dna encoding chitin deacetylase |
09/27/1995 | EP0673421A1 Allergenic proteins and peptides from johnson grass pollen |
09/27/1995 | EP0673380A1 Water soluble camptothecin derivatives |
09/27/1995 | EP0673379A1 Antitumour agents |
09/27/1995 | EP0673378A1 New triazolopyrimidones, their preparation and their use. |
09/27/1995 | EP0673377A1 New triazoloquinazolines, their production and their use. |
09/27/1995 | EP0673376A1 Novel bicyclic pyrimidine compounds, method for preparing same and pharmaceutical compositions containing said compounds. |
09/27/1995 | EP0673375A1 Fused benzo compounds |
09/27/1995 | EP0673374A1 Pharmaceutical composition containing bicyclic type compounds |
09/27/1995 | EP0673373A1 Bicyclic compounds with pharmaceutical activity |
09/27/1995 | EP0673372A1 Novel taxoids, preparation thereof and pharmaceutical compositions containing same |
09/27/1995 | EP0673371A1 Benzazepinone derivatives |
09/27/1995 | EP0673370A1 Tropone-substituted phenyloxazolidinone antibacterial agents |
09/27/1995 | EP0673369A1 Substituted benzazepinones |
09/27/1995 | EP0673368A1 Novel nicotinic acid esters |
09/27/1995 | EP0673367A1 4-aminomethyl/thiomethyl/sulfonylmethyl-4-phenylpiperidines as tachykinin receptor antagonists |
09/27/1995 | EP0673366A1 5-methanesulfonamido-1-indanones as an inhibitor of cyclooxygenase-2 |
09/27/1995 | EP0673360A1 Aminomethylindans, -benzofuranes and -benzothiophenes |
09/27/1995 | EP0673253A1 Antacid composition and method of production |
09/27/1995 | EP0673252A1 Administration of oligonucleotides antisense to dopamine receptor mrna for diagnosis and treatment of neurological pathologies |
09/27/1995 | EP0673251A1 17 substituted acyl-3-carboxy 3,5-diene steroidals as 5-alpha-reductase inhibitors |
09/27/1995 | EP0673250A1 Ophthalmic compositions comprising emedastine and their use for treating allergic conjunctivitis |
09/27/1995 | EP0673249A1 Triazoloquinazolines for the treatment of diseases of the central nervous system |
09/27/1995 | EP0673248A1 Potassium channel activators for use in therapy |
09/27/1995 | EP0673247A1 Fibrinogen receptor antagonists |
09/27/1995 | EP0673245A1 Effervescent pharmaceutical composition containing ibuprofen and method for preparing same. |
09/27/1995 | EP0673244A1 System for dispensing pharmaceutically active compounds |
09/27/1995 | EP0673241A1 A free radical quenching liposomal composition |
09/27/1995 | EP0673240A1 Stabilized medicinal aerosol solution formulations |
09/27/1995 | EP0673239A1 Aqueous antibiotic composition for veterinary use |
09/27/1995 | EP0673238A1 Use of a simarouba extract to reduce patchy skin pigmentation |
09/27/1995 | EP0616525B1 Pharmaceutical aerosol formulation |
09/27/1995 | EP0549621B1 New leukotriene-b4 antagonists, process for producing the same and their use as medicinal drugs |
09/27/1995 | EP0538469B1 Sulfonanilide derivative and medicine |
09/27/1995 | EP0531548B1 Carbostyril derivatives as anti-thrombotic agents |
09/27/1995 | EP0529022B1 New leukotriene b 4? derivatives, method for preparing them and their use as drugs |
09/27/1995 | EP0526535B1 Cyclic hydroxamic acids and their use |
09/27/1995 | EP0521103B1 Novel cyclopropyl squalene derivatives and their use as inhibitors of cholesterol synthesis |
09/27/1995 | EP0510003B1 Piperidine and pyrrolidine derivatives |
09/27/1995 | EP0462189B1 Combination therapy for treatment of estrogen sensitive diseases |
09/27/1995 | EP0455769B1 Use of 7-oh-1,2-benzopyrone for the manufacture of a medicament for the treatment of malignant tumours in humans |
09/27/1995 | EP0311677B1 Cough/cold mixtures comprising non-sedating antihistamine drugs |
09/27/1995 | CN1109260A A retroviral vector capable of transducing the aldehyde dehydrogenase-1 gene and uses of said vector |
09/27/1995 | CN1109057A 咪唑并哒嗪 Imidazopyridazine |
09/27/1995 | CN1109056A Imidazopyridines |
09/27/1995 | CN1109055A 4-aminopyrimidine derivatives |
09/27/1995 | CN1109054A Oxazolidin-2-one derivatives |
09/27/1995 | CN1109051A 3-(phenylalkyl aminoalkyloxy)-5-phenlpyrazol, production, medium and pharmaceutical of same |
09/27/1995 | CN1109050A Catecholamine surrogates useful as beta3 agonists |
09/27/1995 | CN1108968A Use of ion exchange resins loaded with quioolonecarboxylic acid derivatives |
09/27/1995 | CN1108940A 乳酸软膏 Lactic acid ointment |
09/27/1995 | CN1108935A Agent of composition containing quanoxaline and riboside |
09/27/1995 | CN1108934A Pharmaceutical compositions and usages |
09/27/1995 | CN1108933A Nifedipine injection |
09/27/1995 | CN1108932A Methods of increasing thrombemodulin expression |
09/27/1995 | CN1108931A Rapamycin formulations for oral administration |
09/27/1995 | CN1108930A Soft gelatin capsule manufacture |
09/27/1995 | CN1108929A Sugar-coated pharmaceutical dosage unit |
09/27/1995 | CN1108928A One-step process for producing polyvinyl pyrrolidone-iodine aerosol |
09/27/1995 | CN1108927A Silica ketoconazole ointment and its preparation |
09/27/1995 | CN1029846C Compounds for treating inflammatory bowel disease |
09/26/1995 | US5453533 Enzyme inhibitor |
09/26/1995 | US5453524 Phosphorus-containing isoprenoid derivatives |
09/26/1995 | US5453520 Baccatine III derivatives |
09/26/1995 | US5453518 Flavone derivatives |
09/26/1995 | US5453507 Amidation, cyclization |
09/26/1995 | US5453497 Process for producing N4 -acyl-5'-deoxy-5-fluorocytidine compounds |
09/26/1995 | US5453488 Amino-substituted heterocycles as renin inhibitors |
09/26/1995 | US5453471 Gas phase polymerization process |
09/26/1995 | US5453461 Biologically active polymers |
09/26/1995 | US5453447 Preparation of stable injectable β-carotene solubilizates |
09/26/1995 | US5453446 Use of rasagiline or salts thereof |
09/26/1995 | US5453445 Lidocaine free base and phenylephrine hydrochloride dissolved in specified fluorinated ethane and propane solvents |
09/26/1995 | US5453444 Method to mitigate or eliminate weight loss |
09/26/1995 | US5453442 Chromene derivative |
09/26/1995 | US5453441 Enzyme inhibitors and hypertensive agents |
09/26/1995 | US5453439 Hydroxylamine derivatives |
09/26/1995 | US5453438 Hydroxamic acid based collagenase inhibitors |
09/26/1995 | US5453436 Treatment of athereosclerosis using, carbazolyl-(4)-oxypropanolamine compounds |
09/26/1995 | US5453433 Viricides; antiseptics to decontaminate polio, rhino and coxsackie viruses |
09/26/1995 | US5453431 Use of hydroxychloroquine for treatment of graft-versus-host disease |
09/26/1995 | US5453430 1-[2-(arylsulphonylamino)-1-oxoethyl]piperidine derivatives, their preparation and their therapeutic application |
09/26/1995 | US5453429 Crosslinked anion exchange particles and method for producing the particles |
09/26/1995 | US5453428 Method and composition for the treatment of apathy-amotivation syndrome |
09/26/1995 | US5453425 Risperidone oral formulation |
09/26/1995 | US5453424 Antiarrhythmia |
09/26/1995 | US5453423 Respiratory system disorders |
09/26/1995 | US5453421 Antiarrythmia/antiischemic agents; treatment of cardiovascular disorders |
09/26/1995 | US5453283 Orally administered solvent-free pharmaceutical preparation with delayed active-substance release, and a method of preparing the preparation |
09/26/1995 | US5453282 Dietary lipid digestion-absorption inhibitory agents and ingesta |
09/26/1995 | US5453280 Suspension with stirring in water immiscible nonsolvent; sustained release |
09/26/1995 | US5453276 Antimicrobial compositions of indole and naturally occurring antimicrobials |
09/26/1995 | US5453273 M. canis containing ringworm vaccine |
09/26/1995 | CA2145476A1 Sulfonamidocarbonylpyridine-2-carboxamides and their pyridine-n-oxides, process for their preparation, and their use as pharmaceuticals |
09/26/1995 | CA2145475A1 Sulfonamidocarbonylpyridine-2-carboxesteramides and their pyridine-n-oxides, process for their preparation, and their use as pharmaceuticals |